Lazard Asset Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
Lazard Asset Management's GMAB Position: Q1 2024 in Review
Lazard Asset Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 879 shares — an estimated $27K sold.
Lazard Asset Management first reported a position in GMAB in Q3 2019 and held it in 18 quarters. The position peaked at $37.5M in Q4 2019. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.
- Lazard Asset Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
- Lazard Asset Management sold 879 Genmab shares in Q1 2024, an estimated $27K.
- Lazard Asset Management first reported a position in Genmab in Q3 2019 and held it in 18 quarters.
- Lazard Asset Management's Genmab position peaked at $37.5M in Q4 2019.
- 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.
Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.